Emergent BioSolutions is reducing investment in and focus on growing its CDMO services business, and is reducing operations at its Bayview facility in Baltimore, MD. The company will also reduce operations at its facility in Canton, MA, following changes in the volume of U.S. government procurements of medical countermeasures. This will also result in a reduction in operations at the company’s Rockville, MD drug product facility.   Emergent will lay off approximately 400 employees across all a...